Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy

Digestive Diseases and Sciences

Volumn 43, Issue 10, 1998, Pages 2267-2270

  Ter Borg, Frank ^a   Smorenburg, Suzanne ^b   De Man, Robert A ^b   Rietbroek, Ron C ^b   Chamuleau, Rob A F M ^b   Jones, E Anthony ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Antiviral therapy; Chemotherapy; Hepatitis B; Lamivudine; Reactivation

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DNA; ETOPOSIDE; LAMIVUDINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHORIOCARCINOMA; DISEASE COURSE; FEMALE; HEPATITIS B; HUMAN; LIVER FUNCTION TEST; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS REPLICATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHORIOCARCINOMA; FEMALE; GLUCOCORTICOIDS; HEPATITIS B; HUMANS; LAMIVUDINE; LUNG NEOPLASMS; PREDNISOLONE; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0031766492     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026622807373     Document Type: Article

References (25)

1. Hoofnagle JH, Dusheiko GM, Schafer DF, Jones EA, Micetich KC, Young RC, Costa J: Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 96:447-449, 1982
2. Thung SN, Gerber MA, Klion F, Gilbert H: Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch Intern Med 145:1313-1314, 1985
3. Tassopoulos NC, Papaevangelou GJ, Roumeliotou-Karayannis A, Smedile A, Engle R, Ticehurst JR, Feinstone SM, Purcell RH: Fulminant hepatitis in asymptomatic hepatitis B surface antigen carriers in Greece. J Med Virol 20:371-379, 1986
4. Bird GLA, Smith H, Portmann B, Alexander GJM, Williams R: Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med 73:895-902, 1989
5. Lau JYN, Lai CL, Lin HJ, Lok ASF, Liang RHS, Wu PC, Chan TK, Todd D: Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med 73:911-917, 1989
6. Pinto PC, Hu E, Bernstein-Singer M, Pinter-Brown L, Govindarajan S: Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer 65:878-884, 1990
7. Flowers MA, Heathcote J, Wanless IR, Sherman M, Reynolds WJ, Cameron RG, Levy GA, Inman RD: Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy. Ann Intern Med 112:381-382, 1990
8. Soh LT, Ang PT, Sng I, Chua EJ, Ong YW: Fulminant hepatic failure in non-Hodgkin lymphoma patients treated with chemotherapy. Eur J Cancer 28A:1338-1339, 1992
9. Lau JYN, Bird GLA, Gimson AES, Alexander GJM, Williams R: Treatment of HBV reactivation after withdrawal of immunosuppression. Lancet 337:802-802, 1991
10. Yoshiba M, Sekiyama K, Sugata F, Okamoto H, Yamamoto K, Yotsumoto S: Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci 37:1253-1259, 1992
11. Yoshiba M, Sekiyama K, Iwabuchi S, Takatori M, Tanaka Y, Uchikoshi T, Okamoto H, Inoue K, Sugata F: Recurrent fulminant hepatic failure in an HB carrier after intensive chemotherapy. Dig Dis Sci 38:1751-1755, 1993
12. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R: Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345:1406-1407, 1995
13. Lok ASF, Liang RHS, Chiu EKW, Wong KL, Chan TK, Todd D: Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology 100:182-188, 1991
14. Thomas HC: Acute liver decompensation on withdrawal of cytotoxic chemotherapy in hepatitis B carriers: Implications for the treatment of chronic HBV carriers. Q J Med 270:873-874, 1989
15. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M: A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333:1657-1661, 1995
16. Newlands ES, Bagshawe KD, Begent RHJ, Rustin GJS, Holden L: Results of the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumors, 1979 to 1989. Br J Obstet Gynaecol 98:550-557, 1991
17. Bergmeyer HU, Horder MH, Rej R: IFCC methods for the measurement of catalytic concentrations of enzymes. Part 3: IFCC method for alanine aminotransferase. J Clin Chem Biochem 24:481-495, 1986
18. Zaaijer HL, ter Borg F, Cuypers HTM, Hermus CAH, Lelie PN: Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol 32:2088-2091, 1994
19. Hoofnagle JH, Davis GL, Pappas SC, Hanson RG, Peters M, Avignan MI, Waggoner JG, Jones EA, Seeff LB: A short course of prednisolone in chronic type B hepatitis. Ann Intern Med 104:12-17, 1986
20. Mangia A, Chung YH, Hoofnagle JH, Birkenmeyer L, Mushahwar IK, Di Bisceglie AM: Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg. Dig Dis Sci 41:2447-2452, 1996
21. Roingeard P, Romet-Lemonne JL, Leturcq D, Goudou A, Essex M: Hepatitis B core antigen (HBcAg) accumulation in an HBV nonproducer clone of HepG2 transfected cells is associated with cytopathic effect. Virology 179:113-120, 1990
22. Martin BA, Rowe JM, Kouides PA, DiPersio JF: Hepatitis B reactivation following allogeneic bone marrow transplantation: Case report and review of the literature. Bone Marrow Transplant 15:145-148, 1995
23. McIvor C, Morton J, Bryant A, Cooksley G, Durrant S, Walker N: Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation. Ann Intern Med 121:274-275, 1944
24. Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA: Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA 83:1627-1627, 1986
25. Cheng AL: Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma. Blood 87:1202-1202, 1996